 |
|
Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience
Sang Seok Lee, Hyun Sung Shin, Hyung Joon Kim, Su Jin Lee, Hyun Suk Lee, Kyung Hee Hyun, Yong Hyun Kim, Byoung Woon Kwon, Jin Hyung Han, Hoon Choi, Bae Hwan Kim, Joon Hyuk Lee, Ha Yan Kang, Hyun Deok Shin, Il Han Song
Korean J Hepatol. 2012;18(1):48-55. Published online 2012 Mar 22 DOI: https://doi.org/10.3350/kjhep.2012.18.1.48
|
|
Citations to this article as recorded by
 Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop
Caiqun Bie, Yanfang Chen, Huijun Tang, Qing Li, Lu Zhong, Xiaojuan Peng, Ying Shi, Junqin Lin, Junlong Lai, Shenglan Wu, Shaohui Tang
Digestive Diseases and Sciences.2022; 67(2): 569. CrossRef Hepatocellular Carcinoma (HCC) in North-Western India: A Retrospective Study Focusing on Epidemiology, Risk Factors, and Survival
Sweta Soni, Puneet Pareek, Satya narayan, Amrita Rakesh, Abhilasha Abhilasha
Journal of Gastrointestinal Cancer.2022; 53(4): 921. CrossRef Zingerone suppresses proliferation, invasion, and migration of hepatocellular carcinoma cells by the inhibition of MTDH-mediated PI3K/Akt pathway
Jian Fang, Huifen Zhu, Pengcheng Xu, Renya Jiang
Journal of Receptors and Signal Transduction.2022; 42(4): 409. CrossRef Comprehensive Analysis of Prognostic Value and Immune Infiltration of the NT5DC Family in Hepatocellular Carcinoma
Rongqi Li, Rongqiang Liu, Shiyang Zheng, Wenbin Liu, Hui Li, Dewei Li, Alessandro Granito
Journal of Oncology.2022; 2022: 1. CrossRef Integrated Analysis Revealing the Senescence-Mediated Immune Heterogeneity of HCC and Construction of a Prognostic Model Based on Senescence-Related Non-Coding RNA Network
Yanan Jiang, Kunpeng Luo, Jincheng Xu, Xiuyun Shen, Yang Gao, Wenqi Fu, Xuesong Zhang, Hongguang Wang, Bing Liu
Frontiers in Oncology.2022;[Epub] CrossRef Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients Christina Jensen, Signe Holm Nielsen, Mohammed Eslam, Federica Genovese, Mette Juul Nielsen, Roslyn Vongsuvanh, Raj Uchila, David van der Poorten, Jacob George, Morten Asser Karsdal, Diana Julie Leeming, Nicholas Willumsen
Journal of Hepatocellular Carcinoma.2020; Volume 7: 301. CrossRef Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma
Chun-yan Wang, Shengmian Li
Medicine.2019; 98(4): e14070. CrossRef Analyses of a Panel of Transcripts Identified From a Small Sample Size and Construction of RNA Networks in Hepatocellular Carcinoma
Zhiyong Sheng, Xiaolin Wang, Geliang Xu, Ge Shan, Liang Chen
Frontiers in Genetics.2019;[Epub] CrossRef Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
Omar Elshaarawy, Alzhraa Alkhatib, Mostafa Elhelbawy, Asmaa Gomaa, Naglaa Allam, Ayman Alsebaey, Eman Rewisha, Imam Waked
World Journal of Hepatology.2019; 11(6): 542. CrossRef A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients
Ashraf O. Abdelaziz, Hend I. Shousha, Ahmed H. Abdelmaksoud, Yasmin Saad, Tamer M. Elbaz, Zeinab A. Soliman, Ayman Salah, Rania Lithy, Mona Ahmed, Mohamed M. Nabil
European Journal of Gastroenterology & Hepatology.2018; 30(5): 514. CrossRef The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population
Rui-Dong Li, Yan-Hua Tang, Hui-Li Wang, Dong Yang, Li-Jun Sun, Wei Li
Pathology - Research and Practice.2018; 214(5): 625. CrossRef Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis
Marie Lequoy, Christèle Desbois‐Mouthon, Dominique Wendum, Vandana Gupta, Jean‐Luc Blachon, Olivier Scatton, Sylvie Dumont, Mireille Bonnemaire, Fabien Schmidlin, Olivier Rosmorduc, Laetitia Fartoux
Histopathology.2017; 70(3): 492. CrossRef Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease
Lamiaa Mobarak, Dalia Omran, Mohammed M. Nabeel, Zeinab Zakaria
Journal of Medical Virology.2017; 89(6): 1062. CrossRef Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma
Jeong Won Lee, Sang Hyun Hwang, Do Young Kim, Kwang-Hyub Han, Mijin Yun
Clinical Nuclear Medicine.2017; 42(1): e35. CrossRef Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
Zhiwu Jiang, Xiaofeng Jiang, Suimin Chen, Yunxin Lai, Xinru Wei, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, Qiubin Liang, Qifa Liu, Muyun Peng, Fenglei Yu, Jianyu Weng, Xin Du, Duanqing Pei, Pentao Liu, Yao Yao, Ping Xue, Peng Li
Frontiers in Immunology.2017;[Epub] CrossRef Secreted phosphoprotein 24 kD (Spp24) inhibits growth of hepatocellular carcinoma in vivo
Lifeng Lao, Jia Shen, Haijun Tian, Guibin Zhong, Samuel S. Murray, Jeffrey C. Wang
Environmental Toxicology and Pharmacology.2017; 51: 51. CrossRef XRCC1 and XPD polymorphisms and their relation to the clinical course in hepatocarcinoma patients
Qinghai Guan, Zhiqiang Chen, Qiangpu Chen, Xuting Zhi
Oncology Letters.2017; 14(3): 2783. CrossRef Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101
Xuecheng Lv, Jinghua Li, Bingnan Yang
Oncology Reports.2016; 36(4): 2184. CrossRef Importance of SALL4 in the development and prognosis of hepatocellular carcinoma
Fei Yin, Xin Han, Shu-Kun Yao, Xiao-Ling Wang, Hui-Chai Yang
World Journal of Gastroenterology.2016; 22(9): 2837. CrossRef Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease
Fernando Ezquer
World Journal of Gastroenterology.2016; 22(1): 24. CrossRef Mitochondrial DNA Copy Number in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma
Doaa I. Hashad, Amany S. Elyamany, Perihan E. Salem
Genetic Testing and Molecular Biomarkers.2015; 19(11): 604. CrossRef Comparison of Transarterial Chemoembolization and Hepatic Resection for Large Solitary Hepatocellular Carcinoma: A Propensity Score Analysis
Yun Bin Lee, Dong Hyeon Lee, Yuri Cho, Su Jong Yu, Jeong-Hoon Lee, Jung-Hwan Yoon, Hyo-Suk Lee, Hyo-Cheol Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jin Wook Chung, Yoon Jun Kim
Journal of Vascular and Interventional Radiology.2015; 26(5): 651. CrossRef Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?
Chuan Chen, Dong-Ping Chen, Yan-Yan Gu, Liang-Hao Hu, Dan Wang, Jin-Huan Lin, Zhao-Shen Li, Jing Xu, Ge Wang
Tumor Biology.2015; 36(8): 6255. CrossRef Prognostic Significance of Preoperative Serum Alpha-fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China
Song-Lin An, Ting Xiao, Li-Ming Wang, Wei-Qi Rong, Fan Wu, Li Feng, Fa-Qiang Liu, Fei Tian, Jian-Xiong Wu
Asian Pacific Journal of Cancer Prevention.2015; 16(10): 4421. CrossRef High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation
Hyo Jung Cho, Jai Keun Kim, Ji Sun Nam, Hee Jung Wang, Jei Hee Lee, Bong Wan Kim, Soon Sun Kim, Choong Kyun Noh, Sung Jae Shin, Kee Myung Lee, Sung Won Cho, Jae Youn Cheong
Clinical Biochemistry.2015; 48(16-17): 1073. CrossRef Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus
Jung Il Lee, Ja Kyung Kim, Hye Young Chang, Jin‐Woo Lee, Joon Mee Kim, Hyun Jung Chung, Young Soo Kim, Kwan Sik Lee
Journal of Gastroenterology and Hepatology.2014; 29(5): 1019. CrossRef Assessing Prognostic Significance of Preoperative Alpha-Fetoprotein in Hepatitis B-Associated Hepatocellular Carcinoma: Normal is not the New Normal
Sima Blank, Qin Wang, M. Isabel Fiel, Wei Luan, Ki Won Kim, Hena Kadri, John Mandeli, Spiros P. Hiotis
Annals of Surgical Oncology.2014; 21(3): 986. CrossRef Histological improvement following administration of autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study
Yoon Ok Jang, Young Ju Kim, Soon Koo Baik, Moon Young Kim, Young Woo Eom, Mee Yon Cho, Hong Jun Park, So Yeon Park, Bo Ra Kim, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Eun Hee Choi, Yong Man Kim
Liver International.2014; 34(1): 33. CrossRef Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
Yoon Ok Jang, Moon Young Kim, Mee Yon Cho, Soon Koo Baik, Youn Zoo Cho, Sang Ok Kwon
BMC Gastroenterology.2014;[Epub] CrossRef Survival and Prognostic Factors for Hepatocellular Carcinoma: an Egyptian Multidisciplinary Clinic Experience
Ashraf Omar Abdelaziz, Tamer Mahmoud Elbaz, Hend Ibrahim Shousha, Mostafa Mohamed Ibrahim, Mostafa Abdel Rahman El-Shazli, Ahmed Hosni Abdelmaksoud, Omar Abdel Aziz, Hisham Atef Zaki, Inas Anwar Elattar, Mohamed Mahmoud Nabeel
Asian Pacific Journal of Cancer Prevention.2014; 15(9): 3915. CrossRef Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years
Dai Hoon Han, Gi Hong Choi, Jun Yong Park, Sang Hoon Ahn, Kyung Sik Kim, Jin Sub Choi, Kwang-Hyub Han
World Journal of Surgical Oncology.2014;[Epub] CrossRef Management of Hepatocellular Carcinoma: Updated Review
Tamer Elbaz, Mohamed El Kassas, Gamal Esmat
Journal of Cancer Therapy.2013; 04(02): 536. CrossRef
|